Development of the tailor-maid cancer treatment platform with each cancer optimum RI labeling drugs based on the estimation of optimum dose using a fusion technique of CT and PET image analysis and Monte Carlo dose calculation cord
Not Applicable
- Conditions
- ot applicable
- Registration Number
- JPRN-UMIN000025281
- Lead Sponsor
- ational Institutes for Quantum and Radiological Science and Technology
- Brief Summary
Terminated by the change of research field.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
No
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method